🇺🇸

US SEC Filing Intelligence

· daily

High-Value Federal Grants ($5M+) — July 10, 2026

This digest of 18 high-value federal grants, totaling $1.85 billion, reveals a predominantly civilian-agency-driven procurement landscape, with only one defense-related award. The dominant theme is infrastructure modernization, particularly within the Department of Veterans Affairs (VA) and General Services Administration (GSA), alongside niche investments in wildfire suppression and healthcare IT. The highest-conviction signal is the $933.5 million cost-plus-award-fee delivery order to HII Mission Technologies Corp for the JCETII Remote Sensing Center, which underscores sustained DOD R&D spending and strengthens HII's competitive moat. However, the overwhelming neutrality of signals (17 out of 18) and the prevalence of fixed-price construction contracts (e.g., VA EHRM upgrades, GSA seismic retrofits) introduce execution risk, particularly for small businesses. Key risks include potential budget disruptions from a Continuing Resolution (CR) and the concentration of awards to private entities like 10 Tanker Air Carrier, which limits direct investment avenues.

18 total filings
· daily

General Federal Contracts — July 10, 2026

This digest covers 18 federal contracts totaling $1.85 billion, overwhelmingly civilian (17 of 18 awards) with only one defense-related contract. The dominant theme is civilian infrastructure modernization, led by the VA’s EHRM facility upgrades (three awards totaling ~$125M), USDA Forest Service wildfire aviation (three awards totaling ~$104M), and GSA building retrofits. The highest-conviction signal is HII Mission Technologies’ $933.5M cost-plus-award-fee delivery order for JCETII remote sensing support, which strengthens HII’s defense R&D backlog with low margin risk. Key risks include execution pressure from multiple firm-fixed-price construction contracts (VA, GSA, NPS) and budget uncertainty for USAID foreign aid programs. The aggregate signal strength is neutral (5.1/10), reflecting a mix of stable civilian spending and limited defense exposure.

18 total filings
· daily

S&P 500 Technology Sector SEC Filings — July 10, 2026

The S&P 500 Technology sector is showing a stark divergence between capital allocation strategies and insider sentiment. While Accenture has executed a massive $5.0 billion debt issuance to bolster its balance sheet at favorable long-term rates, signaling confidence in its growth trajectory, insider selling at Broadcom and Datadog paints a cautious picture from management. Broadcom's Chief Legal Officer sold $9.48M in a single transaction, and a Director sold an additional $728K, while Datadog's CTO executed a planned 10b5-1 sale of $3.09M. The period-over-period data is limited in these filings, but the capital markets activity and insider patterns suggest a sector where executives are taking profits near recent highs, even as companies like Accenture lock in cheap financing for future investments. The primary theme is a 'mixed signal' environment: strong corporate balance sheet management versus cautious insider behavior.

3 high priority 1 medium 4 total filings
· daily

Nasdaq 100 Stocks SEC Filings — July 10, 2026

Both filings today are from Broadcom Inc., a NASDAQ-100 constituent, and both involve insider stock sales by senior executives. The Chief Legal Officer sold a substantial $9.48M in shares, while a Director sold a smaller $728K position. These transactions, occurring on the same day, create a notable insider selling signal for the company. While the sales are not necessarily indicative of a fundamental deterioration, the concentrated selling by two key insiders warrants close monitoring. The lack of any forward-looking guidance, capital allocation changes, or other operational data in these filings limits the breadth of insights, but the insider activity pattern is the dominant theme.

2 high priority 2 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — July 10, 2026

The July 10, 2026 batch of 47 filings reveals a surge in activist campaigns targeting underperforming micro-cap and small-cap companies, with three new campaigns (Phunware, StealthGas, Evogene) demanding board changes, wind-downs, or strategic alternatives. A major theme is the conversion of active investors to passive status, highlighted by Emirates Telecommunications Group (e&) terminating its relationship agreement with Vodafone and stepping down from the board, and Viking Global reducing its BridgeBio stake below 5%. The data also shows significant insider buying by activist funds at distressed prices, such as Goldenwise Capital's 6.6% stake in Phunware and a 16.7% activist group in Evogene, while institutional investors like Truist and Whitebox Advisors are making incremental, passive adjustments to ETF and trust holdings. The most critical development is the $2.00/share take-private of Perfect Corp., which, while a slight premium, raises questions about minority shareholder value. Overall, the period is characterized by heightened shareholder activism, strategic exits by major holders, and a cautious, passive approach from large financial institutions.

13 high priority 34 medium 47 total filings
· daily

S&P 500 Financials Sector SEC Filings — July 10, 2026

The three S&P 500 Financials filings for July 10, 2026, present a mixed picture with low overall materiality but isolated actionable signals. The most significant development is insider selling at Robinhood Markets, Inc., where a 10% owner executed two trades totaling ~$553K under a 10b5-1 plan, signaling a pre-planned but notable reduction in exposure. Charles Schwab Trust Co's 13F-HR reveals a conservative, heavily ETF-weighted portfolio of $1.79B, with a strategic tilt toward fixed-income (largest holding: Schwab US Aggregate Bond ETF at $152.7M) and large-cap US equities, reflecting a risk-off posture. The Wells Fargo Commercial Mortgage Trust filing is a routine servicer change for a small loan (3.2% of pool), with no financial impact. Period-over-period comparisons are absent from all filings, limiting trend analysis, but the insider selling at Robinhood and the fixed-income bias at Schwab suggest caution within the financial sector. No forward-looking guidance or capital allocation changes were disclosed, but the scheduled events (e.g., earnings calls) and insider activity patterns warrant monitoring for broader sector sentiment shifts.

1 high priority 2 medium 3 total filings
· daily

S&P 500 Energy Sector SEC Filings — July 10, 2026

The two S&P 500 Energy filings for July 10, 2026, reveal a bifurcated sector landscape. Occidental Petroleum's preliminary Q2 2026 data shows a starkly negative natural gas realization, with domestic gas prices at -$1.48/Mcf, a -51% realization vs. NYMEX, signaling severe oversupply and infrastructure constraints in the Permian. This is partially offset by strong oil prices averaging $96.78/bbl worldwide. Meanwhile, Texas Pacific Land Corp saw a small insider purchase by a 10% owner, a positive but low-materiality signal. The key portfolio-level trend is the divergence between robust oil pricing and collapsing gas economics, which will pressure diversified producers and benefit pure-play oil or gas-hedged operators. The lack of forward-looking guidance or capital allocation changes in these filings leaves the sector in a wait-and-see mode ahead of broader Q2 earnings calls.

1 high priority 1 medium 2 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — July 10, 2026

The three filings from S&P 500 Consumer Staples constituents (Hormel Foods and Hershey) on July 10, 2026, exhibit a cautious insider sentiment, highlighted by two notable sales: a $495K sale by a Hormel director and a $1.1M sale by Hershey's 10% owner (the Milton Hershey School Trust) executed under a 10b5-1 plan. While the Hershey Trust sale is pre-planned and not a sudden shift in sentiment, it adds near-term supply. Conversely, a $0 value stock award to Hershey's supply chain chief signals internal retention efforts. The stream shows limited period-over-period or forward-looking data in these specific filings, but the insider activity suggests a tiered conviction level, with insiders at Hormel taking profits and a major trust systematically monetizing Hershey stock. Analysts should monitor upcoming earnings calls for both companies to contextualize these moves.

3 high priority 3 total filings
· daily

S&P 500 Industrials Sector SEC Filings — July 10, 2026

The three filings reveal a bifurcated picture in the S&P 500 Industrials stream. Delta Air Lines, the dominant filer, shows robust top-line growth (revenue up 18.7% YoY in the 10-Q and 13.9% in the 8-K) but severe profit compression, with operating income down 11.3% YoY and pre-tax income falling 25% YoY, driven by a 67-77% surge in fuel costs. This 'growth without earnings' pattern is a key portfolio-level concern. FedEx's 8-K is a low-materiality, procedural debt management filing tied to its Freight spin-off, offering no operational or financial performance data. The primary actionable insight is Delta's mixed signal: strong demand and a 15% dividend hike are bullish, but collapsing margins and a 71% drop in free cash flow are bearish, creating a high-risk, high-reward setup for the airline sector.

1 high priority 2 medium 3 total filings
· daily

US Material Events SEC 8-K Filings — July 10, 2026

The July 10, 2026, digest reveals a market dominated by capital structure engineering and defensive maneuvers, with 50 filings showing a clear bias toward financial restructuring, M&A execution, and governance changes. A significant theme is the prevalence of going-concern risks and cash preservation strategies, highlighted by InnSuites Hospitality Trust's auditor change citing going concern, ZyVersa Therapeutics' cost-cutting measures including potential 'going dark,' and multiple companies (BSTR Holdings, Faraday Future) relying on dilutive financing to survive. Conversely, a few companies are executing growth strategies, such as DXP Enterprises expanding its credit facility by $40M after a period of strong sales growth (sales rising from $1.1B to $2.1B) and Nuveen Churchill Direct Lending upsizing its debt offering. M&A activity is mixed, with a high-value SPAC merger (RF Acquisition Corp III / HCC Healthcare at $500M pre-money) and a strategic pivot by Nu-Med Plus into gold mining, contrasted by the termination of exclusivity in the Coeptis/Skycore deal. Insider activity is limited but notable, with the CEO and CFO of iQSTEL receiving compensation increases and the executives of ZyVersa taking voluntary pay cuts, signaling divergent management confidence. The overall sentiment is cautious, with a heavy focus on liquidity management and structural changes to address stock price or operational challenges.

50 high priority 50 total filings
· daily

Insider Trading Pulse — July 10, 2026

Today's insider trading digest reveals a pronounced bearish tilt among senior insiders, with multiple C-suite officers executing significant sales, often under Rule 10b5-1 plans. The most material insider sales occurred at Aktis Oncology (CMO and COO sold ~$1.7M combined), Casey's General Stores (CFO sold $4.78M), and Insmed (Chair & CEO sold $583K). Notable director-level selling was seen at Hormel Foods ($495K) and United Therapeutics ($179K). The day was dominated by negative sentiment transactions, though several routine option exercises and tax-withholding filings were neutral. A positive signal emerged from Angel Oak Financial Strategies Income Term Trust, where a 10% owner purchased $40M in senior notes. The data suggests insider conviction is weakest in biotech and consumer staples, while capital allocation trends show continued share-based compensation and director awards across technology and healthcare sectors.

50 high priority 50 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — July 10, 2026

All four filings in this digest are Nasdaq-listed companies receiving non-compliance or delisting notices, underscoring a concentrated wave of distress among micro-cap and small-cap issuers. GeoVax Labs, NanoVibronix, Lakeside Holding, and Mercer International each face minimum bid price or stockholders' equity violations, with NanoVibronix at the highest risk due to a prior reverse split that disqualifies it from a standard cure period. Lakeside Holding has already received a second 180-day extension, indicating persistent price weakness. No period-over-period financial data, insider activity, capital allocation, or forward-looking guidance was disclosed in these 8-K filings, limiting quantitative trend analysis. The overarching theme is a liquidity and market confidence crisis, with no clear catalysts for recovery and a high probability of at least one delisting event. Investors should monitor these names for potential bankruptcy or going-concern triggers as they exhaust compliance remedies.

4 high priority 4 total filings
· daily

Global High-Priority Regulatory Events — July 10, 2026

The July 10, 2026, filing batch reveals a pronounced wave of negative corporate actions, with a cluster of delistings (7 filings) and insolvency updates (5 filings) dominating the high-priority event landscape. A significant trend is the surge in SPAC activity, including a major valuation reduction in a pending merger (Plum Acquisition Corp IV cutting its target valuation by 30% to $3.15B) and multiple SPACs extending deadlines or completing IPOs, signaling both opportunity and distress in the blank-check sector. The healthcare and life sciences sector is a focal point for M&A, with GSK's $124/share tender offer for Nuvalent clearing its HSR waiting period and a $500M pre-money SPAC merger for HCC Healthcare. Financial distress is evident across several small-cap companies, with 4 Nasdaq non-compliance/delisting notices and a major fraud declaration by IREDA against Gensol Engineering for ₹672.74 Crore. From a period-over-period perspective, Rotographics' target Teneron showed an 11.3% YoY revenue decline, while Brandywine's office disposition removed $4.7M in quarterly revenue, highlighting asset-level pressure in commercial real estate. Insider activity is limited in this batch, but capital allocation patterns show a mix of strategic M&A, debt financing for acquisitions, and balance sheet restructuring through share cancellations and stock splits.

48 high priority 48 total filings
· daily

US SEC Filings Daily Market Digest — July 10, 2026

Today's filings reveal a market bifurcated between aggressive capital deployment and significant corporate restructuring. The standout event is SK hynix's massive $26.5 billion U.S. IPO, signaling strong demand for AI-related semiconductor exposure. Concurrently, we see a wave of SPAC activity with several transactions (RF Acquisition Corp III, BSTR Holdings, Eureka Acquisition) progressing, though many are renegotiating terms, indicating a maturing SPAC market. Capital return programs are active, with News Corp and Mission Produce executing buybacks, while DXP Enterprises and EquipmentShare are expanding credit facilities and raising guidance, pointing to operational confidence. However, significant risk is present: Zoomcar's massive potential dilution from a proposed 2 billion share increase, Outlook Therapeutics' precarious Nasdaq compliance, and InnSuites' going concern warning highlight ongoing distress in smaller caps. The period-over-period data shows strong growth in semiconductor (ChipMOS +37% YoY) and industrial (DXP sales nearly doubled from 2021 to 2026) sectors, while Ares Management's preliminary estimate of a tripling in performance income underscores robust alternative asset management trends. Insider activity is limited, but the sheer volume of capital markets activity (IPOs, debt offerings, SPAC mergers) suggests a high conviction environment for dealmakers.

13 high priority 37 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — July 10, 2026

The 7 filings from the S&P 500 Consumer Discretionary sector reveal a mixed picture dominated by routine insider transactions and a key executive appointment. Lowe's Companies shows a pattern of director compensation via phantom stock awards, indicating standard retention practices rather than any strategic signal. DoorDash presents a more notable event with its CFO executing a significant stock sale (~$786K) under a 10b5-1 plan, which, while pre-planned, still warrants attention given the size relative to holdings. O'Reilly Automotive's appointment of a new Chief Supply Chain Officer from outside the company suggests a strategic focus on supply chain optimization, a critical area for auto parts retailers. No period-over-period comparisons, forward-looking guidance, capital allocation changes, or M&A activity were present in these filings, limiting the depth of trend analysis. The overall sentiment is neutral to slightly negative, with the DoorDash insider sale being the most material event. The sector appears to be in a steady-state phase with no major disruptions or catalysts emerging from this batch of filings.

7 high priority 7 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — July 10, 2026

The three filings from the S&P 500 Healthcare stream reveal a bifurcated insider activity pattern within the medical technology and biotechnology sectors. Edwards Lifesciences shows a clear divergence: a senior TAVR executive executed a planned sale following option exercise, while the new CFO received a substantial equity grant, signaling confidence in leadership transition. Moderna's director compensation via stock options and RSUs aligns with standard retention practices but offers no new directional signal. No period-over-period financial trends, forward-looking guidance, or capital allocation data were present in these filings, limiting portfolio-level trend synthesis. The key takeaway is the need to monitor Edwards' TAVR segment for potential insider sentiment shifts and to watch for upcoming earnings calls for operational context. Overall, the filings suggest stable governance but no immediate bullish or bearish catalysts from insider activity alone.

3 high priority 3 total filings
· daily

US Earnings Financial Results SEC Filings — July 10, 2026

The 11 filings for the period ending July 10, 2026, reveal a bifurcated market where a few large-cap companies like Delta Air Lines are experiencing strong top-line growth but significant margin compression due to surging input costs (fuel up 67% YoY), while a cluster of micro-cap and pre-revenue companies show nascent signs of revenue generation and cost control, albeit from extremely low bases. A dominant theme is the prevalence of going-concern risks and reliance on non-recurring gains, with 4 out of 11 companies (Radiant Strategies, Lottery.com, Sentinel Holdings, EvoAir) reporting accumulated deficits or negative equity. Insider trading activity was notably absent across all filings, which is a neutral signal but removes a key sentiment gauge. Capital allocation is minimal, with no dividends or buybacks reported, and most companies are in cash preservation or capital-raising modes. The most actionable intelligence comes from the stark contrast between Delta's operational scale and the micro-cap turnaround stories, where the latter show potential for significant revenue growth but carry extreme balance sheet risk.

11 high priority 11 total filings
· daily

US Executive Compensation Proxy SEC Filings — July 10, 2026

This digest of 7 proxy filings reveals a governance landscape dominated by routine director elections and auditor ratifications, but with several high-materiality events that demand investor attention. The most significant development is Modine Manufacturing's pending Reverse Morris Trust transaction with Gentherm, which will reshape its corporate structure and trigger executive departures, including the retirement of Climate Solutions President Eric McGinnis. Aardvark Therapeutics stands out with a potentially dilutive stock option repricing proposal that could signal management's attempt to retain talent or align incentives after a period of underperformance. Lion Copper & Gold's proposed 20:1 to 30:1 share consolidation and quorum increase suggest the company is addressing a low stock price and potential governance vulnerabilities. Insider ownership data from Nexalin Technology shows concentrated insider control at 16.94%, while Dynatrace and Elite Express present standard governance proposals with no material financial disclosures. The overall theme is one of corporate restructuring and governance adjustments, with Modine and Aardvark presenting the most actionable insights for investors.

7 high priority 7 total filings
· daily

US IPO Pipeline SEC S-1 Filings — July 10, 2026

The IPO pipeline on July 10, 2026, is dominated by a wave of S-1 filings from companies in transition—reverse mergers, SPAC combinations, and pivots into digital assets and AI—rather than traditional growth IPOs. A clear theme is the prevalence of resale registrations (6 of 11 filings) that offer no primary capital to issuers, creating significant share overhang and dilution risk for investors. Period-over-period data reveals a stark contrast: Apnimed's revenue surged 2,636% YoY from a related-party deal, while Holtec Nuclear saw a 7.0% revenue decline and a $23.7M operating loss at its Palisades segment. Capital allocation is uniformly non-existent, with no dividends or buybacks across the cohort, and insider activity is absent from all filings. The most critical development is the convergence of digital asset strategies—Avalanche Treasury (SPAC + crypto) and iPower (bitcoin/ethereum treasury)—signaling a new wave of crypto-exposed public entities, albeit with pre-revenue or untested models. Overall, the pipeline is heavy on risk and dilution, with few clear bullish catalysts, making selective, catalyst-driven scrutiny essential.

11 high priority 11 total filings
· daily

US SEC Trading Suspension Halt Orders — July 10, 2026

On July 10, 2026, four micro-cap companies filed 8-Ks disclosing Nasdaq non-compliance, creating a concentrated wave of delisting risk in the small-cap space. All four filings are negative in sentiment, with materiality scores ranging from 8/10 to 9/10, signaling a systemic pattern of distress among low-priced equities. GeoVax Labs (GOVX) faces a stockholders' equity deficiency, while NanoVibronix (FEED), Lakeside Holding (LSH), and Mercer International (MERC) all violate the minimum $1.00 bid price rule. Notably, NanoVibronix is ineligible for the standard 180-day cure period due to a prior reverse split, making it the most acute risk. The concentration of these filings on a single day suggests a potential Nasdaq compliance sweep or broader market pressure on micro-cap stocks. No period-over-period financial trends, insider activity, or capital allocation data were available in these filings, limiting quantitative cross-comparison but highlighting the purely regulatory nature of the risk. The key market implication is a potential wave of delistings that could compress valuations across the micro-cap sector and trigger forced selling by index funds.

4 high priority 4 total filings